Clinical value of tapentadol extended-release in painful diabetic peripheral neuropathy
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical value of tapentadol extended-release in painful diabetic peripheral neuropathy
Authors
Keywords
-
Journal
Expert Review of Clinical Pharmacology
Volume 7, Issue 2, Pages 203-209
Publisher
Informa UK Limited
Online
2014-02-14
DOI
10.1586/17512433.2014.889562
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Comparison between Enriched and Nonenriched Enrollment Randomized Withdrawal Trials of Opioids for Chronic Noncancer Pain
- (2016) Andrea D Furlan et al. Pain Research & Management
- Role of tapentadol in pain management
- (2014) Victor Mendis BRITISH JOURNAL OF HOSPITAL MEDICINE
- Interventional management of neuropathic pain: NeuPSIG recommendations
- (2013) Robert H. Dworkin et al. PAIN
- Guidelines in the management of diabetic nerve pain clinical utility of pregabalin
- (2013) Aaron Vinik et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Tapentadol Extended Release
- (2012) Sheridan M. Hoy DRUGS
- Diabetic neuropathy: clinical manifestations and current treatments
- (2012) Brian C Callaghan et al. LANCET NEUROLOGY
- Tapentadol in Pain Management
- (2011) Craig T. Hartrick et al. CNS DRUGS
- Tapentadol for Multimodal Pain Management
- (2011) Chris Pasero Journal of PeriAnesthesia Nursing
- Evidence-based Guideline: Treatment of Painful Diabetic Neuropathy
- (2011) Vera Bril et al. PM&R
- Efficacy and Safety of Tapentadol Extended Release Compared with Oxycodone Controlled Release for the Management of Moderate to Severe Chronic Pain Related to Osteoarthritis of the Knee
- (2010) Marc Afilalo et al. CLINICAL DRUG INVESTIGATION
- Tapentadol hydrochloride: A centrally acting oral analgesic
- (2010) William E. Wade et al. CLINICAL THERAPEUTICS
- Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution?
- (2010) Keith A. Candiotti et al. CURRENT MEDICAL RESEARCH AND OPINION
- Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial
- (2010) Sherwyn Schwartz et al. CURRENT MEDICAL RESEARCH AND OPINION
- EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
- (2010) N. Attal et al. EUROPEAN JOURNAL OF NEUROLOGY
- Tapentadol and its two mechanisms of action: Is there a new pharmacological class of centrally-acting analgesics on the horizon?
- (2010) Hans G. Kress EUROPEAN JOURNAL OF PAIN
- Tapentadol for acute and chronic pain
- (2010) Paul Sloan EXPERT OPINION ON PHARMACOTHERAPY
- Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study
- (2010) Robert Buynak et al. EXPERT OPINION ON PHARMACOTHERAPY
- Long-term Safety and Tolerability of Tapentadol Extended Release for the Management of Chronic Low Back Pain or Osteoarthritis Pain
- (2010) James E. Wild et al. Pain Practice
- Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrument
- (2009) D. Andrew Tompkins et al. DRUG AND ALCOHOL DEPENDENCE
- Pathophysiology and treatment of painful diabetic neuropathy
- (2008) Mitra Tavakoli et al. Current Pain and Headache Reports
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now